Comparison of two anesthetic agents in electric shock therapy for psychiatric illnesses
- Conditions
- Health Condition 1: null- Psychiatric patients
- Registration Number
- CTRI/2018/08/015218
- Lead Sponsor
- Samiksha kumari
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1)Adult patients of equal number of males and females, aged between 18 to 55 years.
2)Patients belonging to American Society of Anesthesiologist Grade I and II.
3)Patients scheduled for electroconvulsive therapy.
1)Patient or relatives refusal for electroconvulsive therapy or both.
2)Patients with known allergy to the study drug.
3)Patients with full stomach, neuromuscular disorders, displaced bone fractures, severe osteoporosis.
4)Patients with history of recent myocardial infarction ( <3 months), recent cerebrovascular accident or raised ICP.
5)Patients with epilepsy
6)Patients with hypopituitarism and major illnesses like bronchial asthma and tuberculosis.
7)Pregnant patients.
8)Agitated patients requiring additional sedation.
9)ASA grade III and IV patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Measurement of motor seizure duration in isolated limb in seconds for both the drugsTimepoint: Measurement of motor seizure duration in isolated limb in seconds just after giving electric shock for both the drugs
- Secondary Outcome Measures
Name Time Method Recovery parameters <br/ ><br>Any side effectsTimepoint: Intra-operatively and after every 5 min after the procedure